Replicating Global Brain Connectivity as an Imaging Marker for Depression – Influence of Preprocessing Strategies and Randomized Placebo-Controlled Ketamine Treatment
View ORCID ProfileChristoph Kraus, Anahit Mkrtchian, Bashkim Kadriu, Allison C. Nugent, Carlos A. Zarate Jr., Jennifer W. Evans
doi: https://doi.org/10.1101/19010504
Christoph Kraus
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
2Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
MDAnahit Mkrtchian
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
3Institute of Cognitive Neuroscience, University College London, London, United Kingdom
MScBashkim Kadriu
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
MDAllison C. Nugent
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
4Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
PhDCarlos A. Zarate Jr.
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
MDJennifer W. Evans
1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
PhDData Availability
All data and code are available from Dr. Carlos Zarate upon request.
Posted November 12, 2019.
Replicating Global Brain Connectivity as an Imaging Marker for Depression – Influence of Preprocessing Strategies and Randomized Placebo-Controlled Ketamine Treatment
Christoph Kraus, Anahit Mkrtchian, Bashkim Kadriu, Allison C. Nugent, Carlos A. Zarate Jr., Jennifer W. Evans
medRxiv 19010504; doi: https://doi.org/10.1101/19010504
Replicating Global Brain Connectivity as an Imaging Marker for Depression – Influence of Preprocessing Strategies and Randomized Placebo-Controlled Ketamine Treatment
Christoph Kraus, Anahit Mkrtchian, Bashkim Kadriu, Allison C. Nugent, Carlos A. Zarate Jr., Jennifer W. Evans
medRxiv 19010504; doi: https://doi.org/10.1101/19010504
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (205)
- Cardiovascular Medicine (2966)
- Dermatology (251)
- Emergency Medicine (445)
- Epidemiology (12794)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4614)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (930)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4396)
- Nursing (237)
- Nutrition (646)
- Oncology (2287)
- Ophthalmology (651)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6987)
- Radiology and Imaging (1541)
- Respiratory Medicine (918)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)